REDWOOD CITY, Calif., June 8 /PRNewswire-FirstCall/ -- FoxHollow Technologies , which manufactures and markets minimally invasive devices for the treatment of peripheral artery disease, is scheduled to participate in the Goldman Sachs 28th Annual Global Healthcare Conference on Tuesday, June 12, 2007, in Laguna Niguel, California.
John Simpson, chief executive officer, will provide an update on the company at 9:15 a.m. Pacific Time (12:15 p.m. Eastern Time).
A live audio webcast of the presentation will be available via the Internet at http://investor.foxhollowtech.com and will be available for replay for approximately three months.
About FoxHollow Technologies
FoxHollow Technologies, Inc. develops and markets minimally invasive devices for the removal of plaque and thrombus for the treatment of peripheral artery disease (PAD). PAD results from plaque that accumulates in the arteries and blocks blood flow in the legs. These blockages can result in severe pain for patients and very limited physical mobility. The company’s SilverHawk Plaque Excision System is a minimally invasive method of removing the obstructive plaque and restoring blood flow to the legs and feet. The company’s Rinspirator thrombectomy system removes thrombus, or blood clots, from occluded arteries in patients suffering from PAD or coronary artery disease (CAD). For more information, please visit our website at http://www.foxhollowtech.com.
Contacts Investor Relations: Matt Ferguson Chief Financial Officer 650-421-8449 investorrelations@foxhollowtech.com Media Relations: Robin Gaffney 650-421-8614 rgaffney@foxhollowtech.com
FoxHollow Technologies, Inc.
CONTACT: investor relations, Matt Ferguson, Chief Financial Officer,+1-650-421-8449, investorrelations@foxhollowtech.com, or media relations,Robin Gaffney, +1-650-421-8614, rgaffney@foxhollowtech.com, both ofFoxHollow Technologies, Inc.
Web site: http://www.foxhollowtech.com//
